主体和抗生素共同选择 Staphylococcus aureus 的更大的毒性
bioRxiv : the preprint server for biology
|September 11, 2024
概括
宿主和抗生素暴露驱动金黄色葡萄球菌的进化,增加毒性. MSSA进化了降低药物敏感性和增强生物膜,而MRSA显示增长. 同时的选择性压力是病原体适应的关键.
科学领域:
- 微生物学 微生物学
- 进化生物学 进化生物学
- 病原体动力学 病原体动力学
背景情况:
- 抗生素耐药性是一个主要的公共卫生威胁,由病原体进化驱动.
- 主体-病原体相互作用也影响了病原体的进化和疾病的结果.
- 主体因素和抗生素对病原体毒性演变的综合影响尚不清楚.
研究的目的:
- 研究宿主-病原体相互作用和抗生素暴露如何同时影响黄金葡萄球菌毒性的演变.
- 区分宿主环境与抗生素对病原体适应的选择性压力.
- 为了确定病原体适应联合选择性压力的基因变化.
主要方法:
- 在Caenorhabditis elegans线虫中,在12个通道中演变的金黄色葡萄球菌 (MRSA和MSSA菌株) 超过了12个通道.
- 将不断变化的种群暴露在低于最低水平的氧沙林抑制度下.
- 进化菌株的全基因组测序以识别突变.
- 评估进化种群的毒性和药物易感性.
主要成果:
- 黄金葡萄球菌在暴露于亚抑制性抗生素度的线虫中演变为高毒性,无论最初的耐药性如何.
- 对甲素敏感的金黄色葡萄球菌 (MSSA) 进化了对西林的敏感性降低和生物膜形成的增强,这与" `codY`. "的突变有关.
- 与MSSA相比,抗甲素黄金葡萄球菌 (MRSA) 在宿主外的生长增加,与MSSA相比,具有不同的进化路径.
- 在调节毒性和新陈代谢的基因中发现了突变,例如 `codY`, `agr`和 `gdpP`.
结论:
- 同时的宿主和抗生素选择性压力显著推动了病原体的适应和毒性.
- 生物膜形成等特征的进化可以赋予多种适应性益处,影响毒性和耐药性.
- 了解联合选择性压力对于预测病原体进化和管理传染病至关重要.
更多相关视频
相关概念视频
Antibiotic Selection
52.4K
Overview
52.4K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K


